Overview
In the November edition of IPRD Evalueserve’s Newsletter, Legal Watch takes a closer look at pivotal cases shaping the IP landscape. CRISPR Nobelists surrender patents amid an ongoing legal battle, Mylan settles its litigation with Novo Nordisk over generic Ozempic in USA, Apple secures a $250M jury verdict in its patent case over Masimo smartwatches, and Pfizer and BioNTech successfully invalidate CureVac’s UK COVID vaccine patents. Industry News highlights USPTO’s termination of the AFCP 2.0 program and patent applications involving fraudulent signatures, alongside expanded opportunities for practitioners before the PTAB. Additionally, USPTO marks IP Month by introducing new tools to support entrepreneurs and startups.
In Techno Spotlight, this month brings groundbreaking advancements, including AI-enabled breakthroughs that earned this year’s Chemistry Nobel, a new cervical cancer treatment cutting death risk by 40%, and the unveiling of STAR1, the fastest humanoid robot from Chinese startup Robot Era. We also explore BAT’s upcoming launch of synthetic nicotine pouches in the USA, 2D barcodes transforming retail information sharing, and a new study on H5N1 prevalence in U.S. dairy milk. Other highlights include caffeine safety awareness, KAIST’s cutting-edge EV battery diagnostic technology, and the Federal Circuit keeping the door open for antisuit injunctions in Ericsson vs. Lenovo.
Stay tuned for even more innovations and insights!
Subscribe to the Newsletter
Dive in and explore the fascinating world of IP and R&D with us.
